GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **1376 - 1400** of **4050** in total

« First

‹ Prev

…

52

53

54

55

56

57

58

59

60

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▼	Arbitrary Fluorescence Units (AFU)
IgM	Patient 3	11	mild	G63074CQ	126
IgM	Patient 3	4	mild	G63074CQ	131
IgA	Patient 4	12	mild	G63074CQ	343
IgG	Patient 4	12	mild	G63074CQ	86
IgM	Patient 4	12	mild	G63074CQ	175
IgA	Patient 1	10	moderate	G62826CL	356
IgA	Patient 1	22	moderate	G62826CL	318
IgA	Patient 1	6	moderate	G62826CL	271
IgG	Patient 1	10	moderate	G62826CL	28
IgG	Patient 1	22	moderate	G62826CL	35
IgM	Patient 1	10	moderate	G62826CL	33
IgM	Patient 1	22	moderate	G62826CL	100
IgG	Patient 1	6	moderate	G62826CL	25
IgM	Patient 1	6	moderate	G62826CL	35
IgA	Patient 2	15	mild	G62826CL	332
IgA	Patient 2	24	mild	G62826CL	319
IgG	Patient 2	15	mild	G62826CL	2402
IgG	Patient 2	24	mild	G62826CL	2007
IgM	Patient 2	15	mild	G62826CL	118
IgM	Patient 2	24	mild	G62826CL	98
IgA	Patient 2	3	mild	G62826CL	356
IgG	Patient 2	3	mild	G62826CL	3408
IgM	Patient 2	3	mild	G62826CL	145
IgA	Patient 3	-180	mild	G62826CL	251
IgA	Patient 3	11	mild	G62826CL	367